Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Oct-Dec;8(4):445-54.
doi: 10.1111/j.1582-4934.2004.tb00469.x.

Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury

Affiliations
Review

Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury

Wen-Xing Ding et al. J Cell Mol Med. 2004 Oct-Dec.

Abstract

Tumor necrosis factor (TNF)-alpha-induced hepatocyte apoptosis is implicated in a wide range of liver diseases including viral hepatitis, alcoholic hepatitis, ischemia/reperfusion liver injury, and fulminant hepatic failure. TNF-alpha exerts a variety of effects that are mediated mainly by TNF-receptor 1 (TNF-R1) in cell death. The activation of TNF-R1 leads to the activation of multiple apoptotic pathways involving the activation of the pro-death Bcl-2 family proteins, reactive oxygen species, C-Jun NH2-terminal kinase, cathepsin B, acidic sphingomyelinase and neutral sphingomyelinase. These pathways are closely interlinked and mainly act on mitochondria, which release the apoptogenic factors and other events, resulting in apoptosis. This article reviews the recent progress in the molecular mechanisms of TNF-alpha-induced apoptosis in hepatocytes, and discusses how these molecular findings are shaping our understanding of the pathogenesis of liver diseases and our strategy to develop novel therapeutics.

PubMed Disclaimer

References

    1. Yoon J.H., Gores G.J., Death receptor‐mediated apoptosis and the liver, J. Hepatol., 37: 400–410, 2002. - PubMed
    1. Yin X.M., Ding W.X., Death receptor activation‐induced hepatocyte apoptosis and liver injury, Curr. Mol. Med., 3: 491–508, 2003. - PubMed
    1. Wang H., Czura C.J., Tracey K.J., Tumor necrosis factor In: The Cytokine Handbook, 4th Edition (Eds Thomson A.W. & Lotze M.T.). Elsevier Science Ltd, London . 2003. pp. 837–860.
    1. Muto Y., Nouri‐Aria K.T., Meager A., Alexander G.J., Eddleston A.L., Williams, R. , Enhanced tumour necrosis factor and interleukin‐1 in fulminant hepatic failure, Lancet 9;2: 72–74, 1988. - PubMed
    1. Zylberberg H., Rimaniol A.C., Pol S., Masson A., De Groote D., Berthelot P., Bach J.F., Brechot C., Zavala F., Soluble tumor necrosis factor receptors in chronic chepatitis C: a correlation with histological fibrosis and activity, J. Hepatol., 30: 185–191, 1999. - PubMed

Publication types

MeSH terms